HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$1.32
Day range
$1.25 - $1.35
Year range
$1.15 - $2.98
Market cap
4.12M USD
Avg Volume
14.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.24M | -6.79% |
Net income | -3.07M | 7.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.43M | -40.53% |
Total assets | 13.04M | -36.14% |
Total liabilities | 1.29M | 26.44% |
Total equity | 11.75M | — |
Shares outstanding | 3.23M | — |
Price to book | 0.36 | — |
Return on assets | -56.76% | — |
Return on capital | -61.40% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.07M | 7.97% |
Cash from operations | -2.60M | -13.21% |
Cash from investing | 2.74M | 52.62% |
Cash from financing | 32.00K | -76.12% |
Net change in cash | 176.00K | 170.97% |
Free cash flow | -1.42M | -39.81% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
6